Bryan Johnson· Author
he and a bunch of other people are working on this epigenetic reprogramming which is really promising
Loading…
The evidence is convergent. Multiple independent sources reach the same conclusion, the underlying mechanism is well-characterized, and even the field's most cautious voices treat it as worth doing.
he and a bunch of other people are working on this epigenetic reprogramming which is really promising
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
This is one of the first steps towards longevity escape velocity.
Reprogramming as a therapeutic platform is one of the most compelling bets in longevity biotech.